2024 marks the 10th anniversary of the West African Ebola epidemic that took the lives of 11,000 people. In this episode, IDSA President Steven K. Schmitt, MD, FIDSA speaks with Arjun Srinivasan, MD, Deputy Director for Program Improvement in the Division of Healthcare Quality Promotion at the CDC, and Angela Hewlett, MD, MS, FIDSA, Professor in the Division of Infectious Diseases at the University of Nebraska and the George W. Orr MD and Linda Orr Chair in Health Security, about their experiences on the frontline.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

HIV specialist and former punk rock musician, Eamonn Vitt, MD, joins Paul Sax MD, FIDSA, to discuss running a small private practice in NYC and his efforts to seek lower drug costs for his patients.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

More than 200,000 cases of syphilis were reported in the U.S. in 2022, the highest number of cases since the 1950s. In this episode, pediatric ID physician Buddy Creech, MD, MPH, FPIDS, speaks to Laura Bachmann, MD, MPH, Chief Medical Officer in the Division of STD prevention at the CDC, about attributing factors and what providers can do to address this rising epidemic.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

John Fangman, MD discusses opportunities for Medicaid program to cover health-related social needs, such as housing, nutrition and transportation with Katie Garfield, JD, Director of the Center for Health Law and Policy Innovation of Harvard Law School’s Whole Person Care initiative and Michelle Collins-Ogle, MD, Director Montefiore Adolescent & Youth Sexual-health Clinic and Associate Professor of Pediatrics at Albert Einstein College of Medicine.See the companion Reimagining Medicaid, How Medicaid Can Help Address Social Determinants of Health Fact Sheet.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

Anna Person, MD, FIDSA discusses opportunities to work with Medicaid managed care plans to optimize HIV care with Jenny Babcock, Senior Vice President for Medicaid Policy and Director of Strategic Operations at Association for Community Affiliated Plans and, Doug Wirth, President and CEO of Amida Care.Engaging Medicaid Managed Care Plans on HIV Access Helping Medicaid Patients Access Their HIV Medications Fact Sheet. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

John Fangman, MD discusses how providers can engage with their state Medicaid programs to reduce barriers to HIV medications with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Ryan Westergaard, MD, PhD, MPH, Professor with the Division of Infectious Disease at the University of Wisconsin and Chief Medical Officer and State Epidemiologist for Communicable Diseases for the Wisconsin Department of Health Services. See the companion Helping Medicaid Patients Access Their HIV Medications Fact Sheet. 

Anna Person, MD, FIDSA discusses Medicaid basics and how the program helps people with HIV with Lindsey Dawson, MPP, Associate Director of HIV Policy and Director of LGBTQT Health at KFF, and Wendy Armstrong, MD FIDSA, Professor of Medicine in the Division of Infectious Diseases and the Vice Chair of Education and Integration at the Emory University School of Medicine. See the companion fact sheet Understanding Why Medicaid Matters for People with HIV.

IDSA Board member Mati Hlatshwayo Davis, MD, MPH, FIDSA, discusses the importance of advocacy, including how IDSA and HIVMA members can get involved, with chair and vice chair of IDSA’s advocacy captain subcommittee, Rachel Bender Ignacio, MD, MPH, FIDSA, and Kinna Thakarar, DO, MPH, FIDSA, as well as IDSA senior vice president of public policy and government relations, Amanda Jezek, and HIVMA executive director, Andrea Weddle. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

As IDSA increases its involvement with state and regional ID societies, IDSA President Steven Schmitt, MD, FIDSA, discusses their value with Immediate Past President Daniel P. McQuillen, MD, FIDSA, President of the Michigan Infectious Diseases Society Anu Malani, MD, FIDSA, and Former President of the Texas ID Society Brad Cutrell, MD, FIDSA. General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

Mati Hlatshwayo Davis discusses the latest information on avian influenza with Demetre Daskalakis, MD, MPH, director of CDC's National Center for Immunization and Respiratory Diseases, Andrew Bowman, DVM, PhD, a veterinarian, epidemiologist and influenza expert at Ohio State University, and Katelyn Jetelina, MPH, PhD, an epidemiologist and data scientist.  *This episode was recorded on May 21, 2024.

ID physician Courtney Harris, MD, FACP, speaks to Paul Sax, MD, FIDSA, about her experience job hunting as an ID fellow and provides tips on how to find your dream job in infectious diseases.  

CID editor-in-chief Paul Sax, MD, FIDSA, speaks with ID physician Darcy Wooten, MD, FIDSA, about her piece in CID's Voices of ID series, "The Arrivals Gate at Heathrow Airport" and the parallel between rom coms and ID. 

In a new crossover episode with the Febrile podcast, host Buddy Creech, MD, MPH, FPIDS, and Febrile creator and infectious diseases physician, Sara Dong, MD, discuss the power of digital education tools on infectious diseases training.

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA, director of health for the city of St. Louis, discusses the clade I mpox response with guests Jennifer McQuiston, DVM, and Agam Rao, MD, FIDSA of the CDC.

Host Buddy Creech, MD, MPH, FPIDS, sits down with filmmaker Michael Graziano to discuss his projects on antimicrobial resistance and the power of film in widening people's perspectives.

In honor of Black History Month, Let’s Talk ID host and IDSA Board member Mati Hlatshwayo Davis, MD, MPH, FIDSA, talks with HIVMA Chair Allison Agwu, MD, ScM, FIDSA, HIVMA Immediate Past Chair Michelle Cespedes, MD, MS, and HIVMA Board member Darrell McBride, DO, about their experiences as Black infectious diseases physicians.

Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.

Let's Talk ID is joining forces with the Curbsiders and the Cribsiders to discuss RSV immunizations! In this crossover episode, host Buddy Creech, MD, MPH, FPIDS shares the latest on RSV immunizations, including mechanisms of action, eligibility criteria, and challenges surrounding finding doses this season. 

Gretchen Arnoczy, MD, speaks to host Paul Sax, MD, FIDSA, about her contribution to CID’s Voices of ID series, Mothers Days, which recounts her COVID-19 professional experience through the lens of four consecutive Mothers’ Days. 

IDSA President Steven Schmitt, MD, FIDSA, Vera Luther, MD, FIDSA and Emily Blumberg, MD, FIDSA analyze the results of the recent ID Match and discuss IDSA’s strategies for bolstering the ID workforce. 

Paul Sax, MD, FIDSA speaks with Abayomi Agbebi, MD, MPH, CWSP of SSM Health Saint Louis University Hospital about his recently published piece in CID's "Voices of ID" series, "Dealing with a Pandemic When You're the Only ID Doctor in Town."

IDSA President Steven Schmitt, MD, FIDSA, Wendy Armstrong, MD, FIDSA, Erin Bonura, MD, FIDSA, discuss the upcoming ID Match, their projections, what it means for the field and how IDSA is addressing ID workforce needs.

In his final President's Podcast, IDSA President Carlos del Rio, MD, FIDSA speaks with Demetre Daskalakis, MD, MPH, Acting Director of the National Center for Immunization and Respiratory Diseases, about his career path as an infectious diseases physician, how the U.S. can end the HIV epidemic and what he plans to discuss during his Joseph E. Smadel lecture at IDWeek 2023.

Three Let’s Talk ID hosts come together to discuss IDWeek, including tips and tricks to navigate the meeting, conference must-haves, embarrassing moments and the best swag they've ever received.

“We want individuals that are practicing in the ID field to feel that IDSA is their home, that they have the support of IDSA in their endeavors.” In September 2023, IDSA introduced a new volunteer structure to better engage members and support its strategic initiatives. In this episode, IDSA President Carlos del Rio, MD, FIDSA and Vice President Tina Tan, MD, FIDSA discuss the decision behind the restructure and explain the differences moving forward.

From academia to industry: “It’s not a one-way valve.” In this episode with host Paul Sax, MD, FIDSA, infectious diseases physician Steven LaRosa, MD shares his journey to industry-sponsored research and its value as an ID career path. 

IDSA President Carlos del Rio, MD, FIDSA discusses what we can expect for the upcoming respiratory virus season with Meghan Pennini, PhD, the Chief Vaccines and Therapeutics Officer for H-CORE (the HHS Coordination Operations and Response Element) and the Office of the Assistant Secretary for Preparedness and Response (ASPR) at HHS.

Only 50% of infectious diseases fellowship positions are filled each year, a growing issue that can be attributed to the financial impact of working in a non-procedural specialty. In the first episode of a two-part series on addressing ID compensation, Let's Talk ID host Buddy Creech, MD,  MPH, FPIDS dives into the complex issue of health care finance. In episode one, Dr. Creech explores ways that infectious diseases physicians can showcase their value and increase their compensation with health policy experts Gabe Roberts, former Director of TennCare, and Nancy-Ann DeParle, former Administrator of the Centers for Medicare and Medicaid Services (CMS).

 Only 50% of infectious diseases fellowship positions are filled each year, a growing issue that can be attributed to the financial impact of working in a non-procedural specialty. In episode two of a two-part series on addressing ID compensation, host Buddy Creech, MD, MPH, FPIDS speaks with IDSA Immediate Past President Daniel McQuillen, MD, FIDSA to discuss what IDSA has been doing over the last three decades to address these fundamental issues. 

The number of foreign medical graduates interested in infectious diseases is increasing. IDSA President Carlos del Rio, MD, FIDSA speaks to fellow Hispanic board members Lilian Abbo, MD, FIDSA, Cesar Arias, MD, MS, PhD, FIDSA and Max Brito, MD, MPH, FIDSA about their journeys to ID as foreign medical graduates and how to foster the next generation of Hispanic ID leaders. 

Forging a career in infectious diseases public health can be an isolating experience. In this episode, Mati Hlatshwayo Davis, MD, MPH, speaks with Virginia Caine, MD, Nahid Bhadelia, MD, MALD and Eric Chow, MD, MS, MPH, about their journeys in public health, including the importance of building accessible career paths for ID fellows. 

IDSA President Carlos del Rio MD, FIDSA sits down with CNN Chief Medical Correspondent Sanjay Gupta, MD to discuss lessons learned from the COVID-19 pandemic and how infectious diseases professionals can effectively communicate with decision makers and the public.

“Everything's negotiable in the locums world.” Locum tenens is a career path that is often discouraged for ID professionals. In this Let’s Talk ID episode with host Paul Sax, MD, FIDSA, locum tenens ID physician Allison Nazinitsky, MD shares how life in locum tenens provides better pay, work-life balance and a sense of appreciation. 

“We need to start dispelling the myth that you're not able to make money doing [what you love].” After matching into physical medicine and rehabilitation and spending a gap year as a hospitalist, Alice Han, MD decided to pursue a career in infectious diseases. In this episode with Dr. Paul Sax, Dr. Han shares the reason she switched specialties, what it’s like working in ID private practice and the key to having professional satisfaction in ID.

Twenty years ago, Buddy Creech, MD, MPH, FPIDS became a pediatric infectious diseases fellow under mega-mentor Kathryn Edwards, MD, FIDSA, FPIDS. In this episode, Dr. Creech is joined by his former mentor to discuss their story, the dynamics of a successful mentee and mentor relationship, and how to mentor trainees in the best way possible.

The lifting of the COVID-19 public health emergency (PHE) at the federal level will have significant impact on clinical, public health and research in infectious diseases beyond. In this episode, director of health for the city of St. Louis Mati Hlatshwayo Davis, MD, MPH is joined by Allison Agwu, MD, ScM, FIDSA and Maximo Brito, MD, MPH, FIDSA to discuss the urgency for prioritizing health equity beyond the COVID-19 Emergency Order Conclusion. 

IDSA President Carlos del Rio MD, FIDSA, discusses the end of the COVID-19 public health emergency (PHE) with White House COVID-19 Response Coordinator Ashish Jha, MD, MPH. 

Buddy Creech, MD, MPH, FPIDS, sits down with guests William Schaffner, MD, FIDSA, and NBC News medical correspondent Erika Edwards to discuss how ID practitioners can be better communicators. 

The next time you take a careful travel history, think what it would be like to ask comedy writer Mike Reiss — he and his wife have been to more than a hundred countries, many of them far from the usual tourist routes. Paul Sax, MD, FIDSA, sits down with Reiss to discuss the good, the bad and the ugly. 

“If you have something to contribute, that contribution is going to be valued.” In 2019, Jasmine Marcelin, MD, FIDSA, became the youngest person to be elected to the IDSA Board of Directors. In this episode, Dr. Marcelin shares her journey, from experiencing “imposter syndrome,” balancing board work with a career and young children, and why age shouldn’t deter you from applying. 

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.

IDSA President-Elect Steven K. Schmitt, MD, FIDSA and IDSA Immediate Past President Daniel P. McQuillen, MD, FIDSA discuss their experience as clinicians serving on the IDSA Board of Directors.   

The ID/EIS joint fellowship streamlines a career path for applicants interested in both the ID fellowship and EIS program. In this episode, IDSA President Carlos del Rio, MD, FIDSA speaks with Molly Paras, MD, Program Director of Massachusetts General Hospital/Brigham and Women’s Hospital Infectious Diseases Fellowship and Eric Pevzner, MD Chief of the Epidemiology and Laboratory Workforce Branch in the Division of Workforce Development at CDC about the new opportunity and the value it will bring to public health. To learn more, visit idsociety.org/ideisfellowship. 

The Bio-Preparedness Workforce Pilot Project was included in the BIO Preparedness Workforce Act that was passed by Congress at the end of 2022. In this episode, IDSA President Carlos del Rio, MD, FIDSA speaks with Paul Pottinger, MD, DTMH, FACP, FIDSA of the University of Washington and Emily Spivak, MD, MHS, FIDSA of the University of Utah about the program and how it will address ID workforce needs. Learn more about the Bio-Preparedness Workforce Pilot Project. 

Mowing a lawn in Martha's Vineyard and getting tularemia. Swimming in Lake Malawi and getting schistosomiasis. In a game that mirrors a fantasy sports draft, Paul Sax, MD, FIDSA and Rebeca Plank, MD, MPH take turns picking favorite ID associations.

IDSA President Carlos del Rio, MD, FIDSA, Wendy Armstrong, MD, FIDSA, FACP and Erin Bonura, MD, discuss medical education including the latest Match results, recruitment challenges and the work of IDSA’s Med Ed Community of Practice. 

Mati Hlatshwayo Davis, MD, MPH and Jessica Snowden, MD, FIDSA share actions that providers and health systems can take to ensure equitable care for Native American and Alaska Native communities.

Igho Ofotokun, MD, FIDSA, principal investigator of the RECOVER study funded by NIH, and Alba Azola, MD, co-director of the Johns Hopkins Post-Acute COVID-19 Team, discuss the latest research on long COVID.

Infectious disease physicians Dr. Valeria Cantos and Dr. Paulina Rebolledo of Emory University School of Medicine discuss their work with the Latino Community Fund to bolster community awareness on COVID-19 boosters and antivirals. 

Kathryn Edwards, MD, FIDSA and Keipp Talbot, MD, FIDSA of Vanderbilt University School of Medicine discuss COVID-19 bivalent vaccine boosters, including how bivalent vaccines are used, the differences between the Moderna and Pfizer boosters and if boosters will become an annual occurrence. 

In honor of Hispanic Heritage Month, IDSA Board member Maximo Brito, MD, FIDSA and panelists Vincent Guilamo-Ramos, Ph.D. and Carina Marquez, MD discuss the rich diversity within Latinx communities, cultural practices to facilitate health interventions, leveraging community partnerships and how to support pathways for Latinx students entering the medical field. 

Mati Hlatshwayo Davis, MD, MPH and Tina Tan, MD, FIDSA discuss the impact COVID-19 has had on maternal mortality, the downstream effects from unequal access to care and how providers can advocate for health equity.    

Pediatric ID physicians Buddy Creech, MD, MPH, FPIDS, PIDS president, and Andi Shane, MD, MPH, discuss COVID-19's impact on the school year ahead. *This episode was recorded on August 9, 2022. 

In this rebroadcast of the COVID-19 Vaccination Education Roundtable Series, Mati Hlatshwayo Davis, MD, MPH and panelists discuss how to ensure COVID-19 vaccination equity for pediatric populations and ways to leverage the lessons learned to reduce the impact of future pandemics, particularly on marginalized and minoritized communities.

How has our knowledge of COVID-19 and how it affects people with HIV evolved? IDSA board member Max Brito, MD, FIDSA of the University of Illinois at Chicago and HIVMA board member Rachel Bender Ignacio, MD, FIDSA of the University of Washington discuss the latest COVID-19 clinical considerations for people with HIV and the broader impacts of the COVID-19 pandemic on the HIV community and efforts to end the HIV epidemic.

Pediatric infectious disease physicians Jason Newland, MD of Washington University of St. Louis and Buddy Creech, MD of Vanderbilt University Medical Center discuss the latest information on COVID-19 pediatric vaccination, including the recent approval of vaccines for children ages 0-5.

COVID-19 Real-Time Learning Network medical editors Varun Phadke, MD and Ethel Weld, MD discuss case studies on COVID-19 outpatient therapeutics.

IDSA COVID-19 Guidelines co-author Amy Shumaker, PharmD and current co-chair of the HIVMA/IDSA HIV Primary Care Guidance Melanie Thompson, MD discuss recently issued guidance on Paxlovid, including managing drug interactions. 

Emergency medicine physician Heatherlee Bailey, MD, FAAEM, FCCM of the Durham VA Medical Center and family medicine physician Scott Hartman, MD of the University of Rochester Medical Center discuss the latest COVID-19 vaccine booster recommendations. *This episode was recorded on May 17, 2022 and produced in partnership with the American Academy of Family Physicians and the Society of Critical Care Medicine. 

Dr. Kathleen Bell, Professor and Chair of the Department of Physical Medicine and Rehabilitation at UT Southwestern Medical Center, and Dr. Nahid Bhadelia, associate professor of infectious diseases at Boston University School of Medicine and founding director of the BU Center of Emerging Infectious Diseases Policy and Research, discuss the latest research and information on long COVID. 

In this rebroadcast of the COVID-19 Real-Time Learning Network’s Cultural Awareness Series, Gayathri Krishnan, MBBS, MD, Arghavan Salles, MD, PhD, and Laila Woc-Colburn, MD, DTM&H, FIDSA and moderator Mati Hlatshwayo Davis, MD, MPH discuss the representation of women in medicine, the impact the pandemic has had on women in the workforce and overcoming barriers to advancement.

IDSA President Daniel McQuillen, MD, FIDSA is joined by CDC Director Rochelle P. Walensky, MD, MPH, FIDSA to discuss the current state of the COVID-19 pandemic and the pivotal role of infectious disease physicians.

IDSA members Archana Chatterjee, MD, FIDSA of Rosalind Franklin University and Myron Cohen, MD, FIDSA of UNC Chapel Hill share insight on COVID-19 vaccines and prevention in immunocompromised individuals, including current recommendations and the role of antibody testing.

IDSA COVID-19 Guidelines co-authors Rajesh Gandhi, MD, FIDSA and Adarsh Bhimraj, MD, FIDSA provide the latest information on COVID-19 treatments, including the potential role of combination therapies, newer therapies such as nirmatrelvir and strovimab, and their thoughts on President Biden's "Test to Treat" initiative.   

Last fall, the IDSA Board of Directors took a fresh look at IDSA’s strategic plan, understanding that now is the time to seize the moment as the important contributions of the ID workforce during the pandemic are front and center. In this episode, IDSA President Daniel McQuillen, MD, FIDSA, IDSA Vice President Steven Schmitt, MD, FIDSA of the Cleveland Clinic, IDSA Treasurer Jeanne Marrazzo, MD, FIDSA of the University of Alabama at Birmingham and IDSA AMR Committee Chair Emily Spivak, MD, FIDSA of the University of Utah discuss three initiatives in which the Board approved significant investments and how they will positively impact the field of ID.

In this rebroadcast of the COVID-19 Real-Time Learning Network’s Cultural Awareness series and in honor of Black History Month, Associate Editor and St. Louis Medical Director Dr. Mati Hlatshwayo Davis speaks with Dr. Taison Bell of the University of Virginia and Dr. Stella Safo of Mount Sinai on the impact that historical medical mistrust among Black communities has had on vaccine uptake. The panelists share examples of trusted messengers effectively engaging in conversations about COVID-19 vaccines within their communities.   

The COVID-19 pandemic has brought health disparities to the forefront of public health. In this episode, Emily Spivak, MD, FIDSA of the University of Utah, and HIVMA Vice Chair Allison Agwu, MD, FIDSA of Johns Hopkins University discuss what’s currently being done to reduce the disparate impact of COVID-19 on certain populations and the changes that need to be made in order to achieve health equity.

The COVID-19 pandemic has pushed the mental and emotional state of frontline clinicians to its limits. In this episode, hosted in partnership with the American College of Emergency Physicians, emergency medicine physician Anthony Cirillo, MD and Corey Feist of the Dr. Lorna Breen Heroes Foundation discuss what’s driving stress and burnout, immediate interventions that can be taken and how changes to health care policy and programs can protect the clinical workforce over the long-term.

IDSA President Daniel McQuillen, MD, FIDSA, IDSA President-Elect Carlos del Rio, MD, FIDSA and John Bridgeland, co-founder and CEO of the COVID Collaborative, discuss how to combat COVID-19 misinformation and the impact misinformation may have on the future of medicine.

How reliable are at-home COVID-19 tests? Are there shortcomings to “testing out” of vaccine mandates? IDSA members Dial Hewlett, MD, FIDSA of the Westchester County Health Department and Nira Pollock, MD, FIDSA of Boston Children’s Hospital join us to discuss the latest on COVID-19 testing. *This episode was recorded on December 6, 2021.

In this episode recorded on December 13th, IDSA President-Elect Carlos del Rio, MD, FIDSA and IDSA Public Health Committee Chair Julie Vaishampayan, MD, FIDSA share what the medical community knows thus far about the Omicron variant, including its impact on current COVID-19 treatments and why testing plays a key role.

Misinformation about COVID-19, including vaccines, treatments and the government’s role, has been fueling vaccine hesitancy. In this episode, IDSA President Dr. Daniel McQuillen, FIDSA, IDSA President-Elect Dr. Carlos del Rio, FIDSA and John Bridgeland, co-founder and CEO of the COVID Collaborative, discuss what is being done to combat misinformation, how to address myths with vaccine hesitant patients, the impact misinformation has on the future of medicine and the latest information on omicron.

COVID-19 Treatment Guideline co-authors Rajesh Gandhi, MD, FIDSA of Harvard University and Adarsh Bhimraj, MD, FIDSA of the Cleveland Clinic give an update on COVID-19 therapeutics and discuss two recently published papers in Clinical Infectious Diseases. Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab882/6398589 Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab880/6398590

Moderator Neil Skolnik, MD and IDSA COVID-19 Guidelines co-author John Lynch, MD, FIDSA discuss the new IDSA guidance on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19. The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to https://www.idsociety.org/practice-guideline/covid-19-guideline-infection-prevention/ (published 11/4/2021) Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health John B. Lynch, M.D. is a Professor in the Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington

In honor of Native American Heritage Month, COVID-19 Real-Time Learning Network Associate Editor Mati Hlatshwayo Davis, MD, MPH, leads a panel discussion with Luke John Day, MD of UCSF, Sophie Neuner, MD, MPH of Johns Hopkins Center for American Indian Health, and Jessica Snowden, MD, FIDSA of UAMS. The group discusses the importance of visibility of native people, historic and modern reasons for mistrust of the health care system, strategies for providing culturally inclusive care and the impact COVID-19 has had on native communities.

IDSA President Daniel McQuillen, MD, FIDSA is joined by Congresswoman Lori Trahan (D-MA) and IDSA Advocacy Liaison Kinna Thakarar, DO to discuss the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act, new bipartisan legislation that would provide loan repayment for medical professionals who work in bio-preparedness or provide infectious diseases care in underserved areas or clinics and facilities that receive federal funding.

Are current vaccination rates in the U.S. enough to bring an end to the pandemic? Keipp Talbot, MD, FIDSA of Vanderbilt University Medical Center and Amber Clayton of the Society for Human Resource Management join us to provide an update on COVID-19 vaccination and employer vaccine mandates.

How is the Delta variant impacting COVID-19 vaccine performance? Why are only certain populations being considered for boosters? Steven Pergam, MD, FIDSA of the Fred Hutchinson Cancer Research Center and Walter Orenstein, MD, FIDSA of Emory University answer these questions and more. *This episode was recorded on Oct. 5, 2021.

IDSA President-Elect Carlos del Rio, MD, FIDSA moderates a discussion with Lilian Abbo, MD, FIDSA, Angelica Cifuentes Kottkamp, MD, and Robert Rodriguez, MD on the impact the COVID-19 pandemic has had on the Latinx community, cultural nuances and practices for engaging in an effective and culturally competent patient-provider relationship and the progress made in developing pathways for the next generation of Hispanic physicians.

With children across the U.S. back in school, have mitigation strategies been effective in preventing the spread of COVID-19? Dr. Jason Newland of Washington University and Noelle Ng of the School Superintendents Association give an update on infection rates among children and share their thoughts on the Delta variant, mask mandates, and testing programs in schools.

In this episode, Dr. Ricardo Franco, Assistant Professor of Medicine at the University of Alabama at Birmingham, and Dr. Josh Barocas, Associate Professor of Medicine and Infectious Diseases Physician at the University of Colorado School of Medicine, examine the COVID-19 Delta variant surge, heated debates surrounding school masking guidelines, and how our nation and the world will achieve herd immunity.

In this episode moderator, Dr. David Weber, asks Dr. Marci Drees, Dr. Trini Mathew, and Dr. Sharon Wright questions surrounding the July 13th multi-society statement about COVID-19 vaccine as a condition of employment. Questions focus on how the societies developed this statement, why it was important to create this statement now, legal & human resources considerations, and more. (Rebroadcast of SHEA Podcast)

With schools set to re-open, the number of children COVID-19 hospitalizations on the rise, and vaccinations not yet authorized for children under age 12, what is the most important thing you can do to protect yourself and others? Dr. Preeti Malani, of the University of Michigan, and Dr. Tina Tan, of Northwestern University, weigh in on back-to-school and vaccination policies.

COVID-19: the race between the variants and the vaccinations. Do desperate times call for desperate measures? HIVMA Chair Rajesh Gandhi, MD, with Harvard University, and 2020 IDSA Society Citation Awardee Adarsh Bhimraj, MD, with the Cleveland Clinic, discuss COVID-19 treatments: the knowns, unknowns, and important factors in stemming the future of the pandemic.

Vaccination rates are inconsistent around the U.S. and globally. Is it safe to travel for summer vacations? Trish Perl, MD, FIDSA, of the University of Texas Southwestern Medical Center, and Preeti Malani, MD, FIDSA, of the University of Michigan, join us to discuss summer vacationing, travel, and how to be safe.

Is the “Fauci effect” enough to attract the number of doctors needed into the field of ID? In this episode, IDSA President Barbara Alexander, MD, FIDSA is joined by Wendy Armstrong, MD, FIDSA, of Emory University School of Medicine, and Michael Melia, MD, FIDSA, of Johns Hopkins School of Medicine, to discuss the current state of the ID Match and IDSA’s efforts to address recruitment into the field as well as its mentorship and professional development efforts.

In this episode, produced in partnership with the Mycoses Study Group Education and Research Consortium (MSGERC), we discuss Mucormycosis: the deadly fungal infection affecting COVID-19 patients in India with IDSA and MSGERC members, Ilan Schwartz, MD, PhD, Assistant Professor in the Division of Infectious Diseases at the University of Alberta, and Andrej Spec, MD, MS, Associate Director of the Infectious Diseases Clinical Research Unit, Director of the Invasive Mycoses Clinic, and Assistant Professor of Medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis.

The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to www.idsociety.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Stuart Johnson, M.D., Professor of Medicine, Loyola University Medical Center; Clinician Researcher, Departments of Research and Medicine, Edward Hines Jr. Veterans Administration Hospital

IDSA Board members Dr. Angela Caliendo, MD, PhD, FIDSA, Professor and Executive Vice Chair of Medicine at Alpert Medical School of Brown University, and Dr. Kimberly Hanson, MD, Professor at the University of Utah School of Medicine discuss Antigen Testing: What it is, what role testing will play from a screening perspective, and testing effectiveness.

In this episode, we discuss the CDC’s new masking guidance, the recommendations, surrounding challenges, and a return to the abnormal with IDSA Board Member and Fellow Dr. Jeanne Marrazzo, Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham, and Dr. Joshua Barocas, member of IDSA’s Public Health Committee and Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center.

IDSA members Krutika Kuppali, MD, of the Medical University of South Carolina, and Dawd Siraj, MD, of the University of Wisconsin-Madison, discuss the rapid rise in COVID-19 cases in India and whether the African continent will face a similar wave soon.

IDSA members Susan Kline, MD, of the University of Minnesota, Monica Gandhi, MD, of UC-San Francisco, and Jason Newland, MD, of Washington University, share thoughts about gatherings, mask protocol, and the trajectory of COVID-19 over the summer.

IDSA members Amesh Adalja, MD, of Johns Hopkins University, and Ali Mokdad, MD, of the Institute for Health Metrics and Evaluation, discuss the Covid-19 forecast for the months ahead and what we can do to prevent future surges in cases.

IDSA members Adarsh Bhimraj, MD, of the Cleveland Clinic, and Rajesh Gandhi, MD, of the Massachusetts General Hospital, discuss what we've learned about COVID-19 treatments as the pandemic has progressed.

IDSA members Anna Person, MD of Vanderbilt University and Kristin Englund, MD of the Cleveland Clinic discuss COVID-19 recovery and the special rehabilitation considerations and resources needed to treat patients.

IDSA President Barbara Alexander, MD, FIDSA sits down with IDSA/HIVMA member and CDC Director Rochelle P. Walensky, MD, MPH, FIDSA to talk about what it has been like to take over the helm of the nation’s top public health agency in the midst of a global pandemic and how her career in infectious diseases helped prepare her for this moment. The two also discuss Dr. Walensky’s priorities beyond the pandemic, her thoughts on the ID workforce and how IDSA, HIVMA and CDC might work together on common goals.

In this episode, produced in partnership with the American Geriatrics Society, we discuss issues surrounding vaccinating vulnerable populations with IDSA member Dr. Joshua Barocas and American Geriatrics Society members, Drs. Timothy Farrell and Melissa Dattalo.

On April 13, 2021, the FDA and CDC recommended a pause in the use of the Johnson & Johnson/Janssen COVID-19 vaccine after cases of a rare form of blood clotting were reported. In this episode, produced in partnership with the American Society of Hematology, we explore the topic of vaccine-induced immune thrombotic thrombocytopenia with hematologists Dr. Jean Connors of Harvard Medical School and Dr. Lisa Baumann Kreuziger of the Versiti Blood Center of Wisconsin.

What have we learned from COVID-19 and how we can be better prepared for future pandemics? IDSA Treasurer Dr. Helen Boucher of Tufts Medical Center, Dr. Angelica Kottkamp of New York University and Dr. Dial Hewlett of the Westchester Department of Health discuss key takeaways. 

What are the most important considerations for full-time in-person learning? When can we expect to see widespread vaccination initiatives for children under the age of 16? Preeti Malani, MD, FIDSA and Tina Tan, MD, FIDSA discuss updates and challenges with in-person learning.

With the accelerated distribution of vaccines, does COVID-19 testing still matter? How reliable are the new, home test kits? IDSA members Mary Hayden, MD, FIDSA of Rush Medical College and Romney Humphries, MD of Vanderbilt University Medical Center share updated considerations for COVID-19 diagnostic testing.

What drug therapies are producing the best outcomes in patients hospitalized with COVID-19? What are the differences in treating patients suffering from severe COVID in the ICU setting versus those receiving non-critical treatment? Dr. Adarsh Bhimraj of the Cleveland Clinic and Dr. Laura Evans, Director of Critical Care at the University of Washington Medical Center, join us to discuss treating hospitalized patients with COVID-19, including the challenges clinicians are facing. This episode is produced in partnership with the Society of Critical Care Medicine. 

What strategies have been the most successful in boosting vaccine distribution and administration, and what key hurdles remain? When can low-risk populations expect to receive the vaccine? Dr. Saad Omer of Yale University and Dr. Matthew Zahn of Orange County Health Care Agency discuss the latest challenges, milestones and issues surrounding COVID-19 vaccine distribution. 

How can ID physicians advocate for improved physician value and compensation? In this episode, IDSA President Barbara Alexander, MD, FIDSA is joined by IDSA President-Elect Daniel McQuillen, MD, FIDSA of Lahey Hospital & Medical Center and Steven Schmitt, MD, FIDSA of the Cleveland Clinic to discuss increasing awareness, public support and compensation for ID professionals.

Should expectant mothers get the COVID-19 vaccine? What do we know about the effectiveness and safety of the vaccine in people with HIV? In this episode, we discuss the COVID-19 vaccine and its possible effect on special populations, such as people living with HIV, pregnant people, and the transplant community with Dr. Rachel Bender Ignacio of the University of Washington, Dr. Denise Jamieson of Emory University and Dr. Aruna Subramanian of Stanford University. This episode is produced in partnership with the American Society of Transplantation and the American College of Obstetricians and Gynecologists. 

Guideline Update: 2020 Guideline on Diagnosis and Management of Babesiosis The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to idsociety.org or see the full article in Clinical Infectious Diseases Volume 72, Issue 2, 15 January 2021, Pages e49–e64, https://doi.org/10.1093/cid/ciaa1216 Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Peter Krause, M.D., Senior Research Scientist in the Department of Epidemiology and Public Health, Yale School of Public Health and Yale School of Medicine, in New Haven, CT

Can masks be removed in crowds or at gatherings if everyone has received the vaccine? What's currently known about effectiveness of the vaccines against SARS-CoV-2 variants and how will it influence recommendations on mask wearing and social distancing? Dr. Joshua Barocas of Boston University School of Medicine and Dr. Ricardo Franco of the University of Alabama at Birmingham answer these questions and more. 

The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases, ciaa1215, https://doi.org/10.1093/cid/ciaa1215 Published: 30 November 2020     Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Paul Auwaerter, M.D. is a professor of medicine at the Johns Hopkins University School of Medicine and serves as the clinical director of the Division of Infectious Diseases.

Should individuals who have already had COVID-19 be vaccinated? In this episode, Rajesh Gandhi, MD, FIDSA of Massachusetts General Hospital and Hana El Sahly, MD, FIDSA of Baylor College of Medicine discuss considerations when administering the COVID-19 vaccine to those with prior COVID-19 infection. 

IDSA President Barbara Alexander, M.D., FIDSA is joined by Luciana Borio, MD, a member of the COVID-19 Advisory Board that convened during the Biden-Harris transition, to discuss the Administration’s COVID-19 strategy, vaccine production and distribution, EUA guidance for COVID-19 therapies and the importance of masking policies.

Preliminary reports indicate some COVID-19 patients may develop a so-called “post-acute COVID-19 syndrome,” in which they experience persistent symptoms after recovering from their initial illness. The syndrome appears to affect those with mild as well as moderate-to-severe disease. In this episode, we're joined by American Thoracic Society member, Dr. Vinay Gupta and Society of Critical Care Medicine member, Dr. Meghan Lane-Fall to discuss what's currently known about the syndrome, also known as Long COVID, and the challenges it presents to both patients and clinicians. For more information on Long COVID, visit the COVID-19 Real-Time Learning Network.  This episode is in partnership with the American Thoracic Society and the Society of Critical Care Medicine.

We discuss the emergence of SARS-CoV-2 variants in the U.S. and the impact they'll have on COVID-19 vaccines and treatments with Kathryn Edwards, MD, FIDSA of Vanderbilt University and Mirella Salvatore, MD, FIDSA with Weill Cornell Medicine. 

In this episode, we explore the Theater of War production and learn how it’s being used as a tool to help frontline healthcare workers cope with the dire realities of the COVID-19 pandemic and focus on better mental health. To discuss are Theater of War Productions Artistic Director, Bryan Doerries and American College of Emergency Physician members, Dr. Diane Birnbaumer of UCLA and Dr. Jay Kaplan of Louisiana State University. This episode is in partnership with the American College of Emergency Physicians.

IDSA President Barbara Alexander, M.D., FIDSA speaks with IDSA Senior Vice President Amanda Jezek about how ID physicians can help shape policy on issues such as AMR and physician compensation. Dr. Alexander explains that, even in the midst of COVID, it’s important to continue promoting the value of ID.

IDSA member Dr. Javeed Siddiqui of TeleMed2U and Dr. Tamaan Osbourne-Roberts with the American Academy of Family Physicians Commission on Quality and Practice join us discuss the rise of telehealth and how it can utilized to treat and care for those battling COVID-19. This episode is in partnership with the American Academy of Family Physicians. 

COVID-19 Testing Guideline Panel members Angela Caliendo, M.D., FIDSA of Brown University and Cesar Arias, M.D., FIDSA of the University of Texas discuss recent changes made to IDSA's COVID-19 Diagnostic Guidelines. 

IDSA Board member John Lynch, M.D., FIDSA, & SHEA/IDSA member Erica Shenoy, M.D., FIDSA discuss how to create safe environments across medical facility departments while treating COVID-19 patients. This episode was produced in partnership with the Society for Healthcare Epidemiology of America.

How do monoclonal antibody treatments help combat COVID-19? In this episode, we discuss the latest information on monoclonal antibodies with Dr. Eric Daar of UCLA Medical Center, Dr. Alyssa Letourneau of Massachusetts General Hospital and Dr. Roger Bedimo of the VA North Texas Health Care System.

How safe and efficient are the current COVID-19 vaccine candidates? How are public health systems and health care providers preparing for vaccine administration? Buddy Creech, M.D. and Kathryn Edwards, M.D., FIDSA of Vanderbilt University and Dial Hewlett, M.D., FIDSA of the Westchester County Department of Health answer those questions and more. 

Dr. Tom Fekete of Temple University, Dr. Eric Wei of Elmhurst Hospital and Dr. Mark Rudolph of Sound Physicians discuss the toll COVID-19 has taken on the mental health of frontline healthcare professionals and why mental health resources and support services are more important than ever.  The episode is in partnership with the Society of Hospital Medicine. 

ABC Chief Medical Correspondent Jennifer Ashton, M.D. joins us to discuss mask mandates, how to reenergize the public's focus on COVID-19 precautions, tips for staying safe this holiday season & why self-care is more important than ever.

From an upbringing in rural North Carolina to becoming the Director of Transplant Infectious Diseases Service at Duke University, get to know IDSA's newest president, Barbara Alexander, M.D., FIDSA, including her plans for the society. IDSA CEO Chris Busky guest moderates.

What does COVID-19 data modeling tell us to expect over the next six months? Amesh Adalja, M.D., FIDSA of Johns Hopkins University and Ali Mokdad, PhD of the Institute for Health Metrics and Evaluation join us to share the forecast.

"In this pandemic, we’re not only fighting a virus, we’re also fighting an 'infodemic.'" IDSA Board members Wendy Armstrong, M.D., FIDSA, and Carlos del Rio, M.D., FIDSA of Emory University discuss the ongoing spread of COVID-19 misinformation and ways to combat it. 

IDSA Board members Jeanne Marrazzo, M.D., FIDSA & John Lynch, M.D. discuss where we are seven months into the COVID-19 pandemic and the lessons we’ve learned thus far.

We discuss how to navigate the upcoming holiday season and family gatherings amid the COVID-19 pandemic with Dr. Jason Newland of Washington University and Dr. Susan Kline of the University of Minnesota.

IDWeek Chair Inger Damon, M.D., Ph.D., FIDSA shares what to expect during the year’s premier infectious diseases event. 

Is in-person learning now considered safe? How can schools prepare for the upcoming winter months? IDSA Board member Tina Tan, M.D., FIDSA of Northwestern University and Preeti Malani, M.D., FIDSA of the University of Michigan join us to share an update on COVID-19 and schools.

"There’s only one enemy here and that enemy is a virus...the more we stick together, learn with each other, support each other, the more we can gain the upper hand." Former CDC director and President & CEO of Resolve to Save Lives, Tom Frieden, M.D., joins us to discuss the biggest obstacles the U.S. is facing amid the COVID-19 pandemic, including vaccine distribution, testing & guidance changes.

What special type of preparations should long-term care facilities deploy in order to keep their residents, staff and visitors from contracting or spreading COVID-19? Dr. Alice Kim of the Cleveland Clinic and Dr. Sean Cannone (D.O.), a geriatric specialist at Summa Western Reserve Hospital, join us to discuss issues surrounding COVID-19 in long-term care facilities.

What do we know about the genetic diversity of SARS-CoV-2 and does an increase in mutations mean COVID-19 is getting more harmful over time? Dr. Adam Lauring of the University of Michigan and Dr. Stanley Perlman of the University of Iowa join us to discuss mutations of the COVID-19 virus.

ER physicians Sandy Schneider, M.D. of the American College of Emergency Physicians & Edward Michelson, M.D. of Texas Tech University Health Services Center discuss issues surrounding COVID-19 and influenza, treatment of each, their effects on medical facilities and how health care professionals can deal with the added challenge. 

What are the benefits and trade-offs of saliva testing compared to other COVID-19 testing methods? IDSA Diagnostics Committee member Dr. Francesca Lee of the University of Texas and Dr. Nathan Grubaugh of Yale School of Public Health join us to discuss the latest on saliva testing. 

CDC global health experts Dr. Barbara Marston & Dr. Nancy Knight join us to discuss the agency’s role in responding to the COVID-19 pandemic globally.

Monica Gandhi, M.D. of the University of California, San Francisco and Chip Schooley, M.D., FIDSA of the University of California, San Diego discuss COVID-19 prevention and why widespread and continued mask use is critical in the fight against the pandemic. 

Drs. Robin Trotman of Cox Health and Inessa Gendlina of Montefiore Medical Center discuss the long-term effects of COVID-19 and how to manage recovered patients. Resources mentioned: Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network Management of post-acute covid-19 in primary care Persistent Symptoms in Patients After Acute COVID-19 COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19 Duration of Isolation and Precautions for Adults with COVID-19  

What are the advantages & limitations of COVID-19 antibody testing? Kim Hanson, M.D. of the University of Utah & IDSA Secretary Angela Caliendo, M.D., FIDSA of Brown University shares key takeaways from IDSA’s new serology guidelines. 

"We know from experience now that we cannot lost our corporate memory. We must be prepared for the next outbreak as we struggle through this one." NIAID Director and IDSA member Anthony Fauci, M.D., FIDSA shares ID insights on the COVID-19 pandemic with guest moderator Carlos del Rio, M.D., FIDSA and answers questions submitted by IDSA members. 

Dr. Jason Newland of Washington University and Dr. Elisa Choi of Harvard University join us to discuss the impact COVID-19 has had on routine medical care, and the dangers of delaying health care and necessary medical procedures.

Is pooled testing the answer to the current testing challenges? What are its limitations? Dr. Romney Humphries of Vanderbilt University and Dr. Melissa Miller of the University of North Carolina at Chapel Hill join us to discuss the benefits and questions surrounding COVID-19 pooled testing practices. 

Are high school, college & professional sports safe to play right now? Dr. John Swartzberg of UC Berkley and Dr. Colleen Kraft of Emory University explain how COVID-19 will impact the world of sports.

Is air travel actually safe right now? Dr. Trish Perl of UT Southwestern Medical Center and Tori Barnes, Executive Vice President of Public Affairs and Policy with the U.S. Travel Association join us to address concerns and questions surrounding travel amid the COVID-19 pandemic.

Dr. Jonathan Iralu of Indian Health Service and Dr. Donald Warne, director of Indians into Medicine, of the University of North Dakota join us to discuss the disparities COVID-19 has brought to light within the Native American population.

From the importance of monitoring community spread to best practices for screening, Wendy Armstrong, M.D., FIDSA of Emory University, Tina Tan, M.D., FIDSA of Northwestern University & Noelle Ellerson Ng, Associate Executive Director, Advocacy and Governance of the Schools Superintendents Association, share how schools and parents should navigate reopening amid the COVID-19 pandemic.

Will re-opening plans be undone by off-campus social life? Preeti Malani, M.D., FIDSA of the University of Michigan and Carlos del Rio, M.D., FIDSA of Emory University discuss the obstacles colleges and universities will face amid the COVID-19 pandemic.

We discuss how health care organizations have been impacted financially by COVID-19, how they're responding and what the plans are for recovery with Russ Petrak, M.D., FIDSA of Metro ID Consultants, Steven Gordon, M.D., FIDSA of the Cleveland Clinic and William Schpero of Cornell Medical College. *This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

Guest moderator Dr. Jasmine Marcelin is joined by Drs. Magdala Chery, Jacinda Abdul & Jessica Queen to discuss the systemic barriers that COVID-19 has brought to light & how health care providers can take action. *This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

How quickly will a COVID-19 vaccine be available, and will it be safe and effective? Dr. Kathryn Edwards of Vanderbilt University and Dr. Walter Orenstein of Emory University join us to discuss the status of a COVID-19 vaccine and the steps necessary to distribute an effective one. *This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

IDSA Global Health Committee Chair Dr. Judith Wasserheit of the University of Washington and Dr. Charles Holmes of Georgetown University join us to discuss the critical role of the World Health Organization in COVID-19 response efforts & how its defunding could impact our ability to prevent, detect & respond to future pandemics. *This episode was recorded prior to the White House’s announcement on July 7th that the U.S. is officially terminating relations with the WHO.

We're joined by Drs. Liise-Anne Pirofski of Albert Einstein College of Medicine & Shmuel Shoham of Johns Hopkins University to examine convalescent plasma and its role in the treatment of COVID-19.

We’re joined by Drs. Adarsh Bhimraj of the Cleveland Clinic & Rajesh Gandhi of Massachusetts General Hospital to discuss all things remdesivir, including how the antiviral combats COVID-19, what will happen if supplies are depleted & the latest clinical trial information.

“This is a long game and we’re maybe in the second inning." Dr. Anurag Malani of St. Joseph Mercy Health System & Dr. Dial Hewlett of Westchester County Department of Health-Disease Control discuss future waves of COVID-19 and how to lessen risks and severity. 

We discuss how COVID-19 is affecting the Latinx community and steps to alleviate disparities with Dr. Vincent Guilamo-Ramos of New York University and the director of the Center for Latino Adolescent and Family Health and Dr. Raul Macias Gil with Brown University.

"There was no sense of what was coming next." Drs. Buddy Creech & Anna Person of Vanderbilt University & Michael Saag of the University of Alabama share their unique experiences as physicians infected with COVID-19.

Pediatric infectious disease physicians Dr. Tina Tan, FIDSA of Northwestern University & Dr. Jason Newland of Washington University join us to discuss how COVID-19 is affecting the pediatric population, including Multisystem Inflammatory Syndrome & if children should be wearing face masks.

Dr. Paul Volberding of The University of California San Francisco and Dr. Fay Hlubocky, a clinical health psychologist from The University of Chicago, join us for a discussion on mental health. We talk about the toll the COVID-19 pandemic has taken on the mental health of healthcare professionals and what can be done to reverse this, while increasing resiliency.

We discuss clinical trials and registries as they relate to the COVID-19 pandemic and their importance in combating the virus with Dr. Gabriela Maron of St. Jude Children’s Research Hospital and Dr. Jeanne Triant with Mass General.

ID medical educators and students share how they’re adapting to the COVID-19 pandemic. This episode includes guest moderator Dr. Anna Person of Vanderbilt School of Medicine, and panelists Dr. Brian Schwartz of the University of California San Francisco, medical student Cassandra Thanh, & Drs. Vera Luther and Kelsie Peirre of Wake Forest University.

We discuss strategies for safely reopening the country with Drs. Carlos del Rio, FIDSA of Emory University and Dr. Preeti Malani, FIDSA of the University of Michigan.

We discuss secondary infections as they relate to COVID-19 and the ways to prevent and treat them successfully with IDSA Board Member, Dr. Helen Boucher of Tufts University & Dr. Neil Clancy of The University of Pittsburgh. 

We discuss the disparate impact of COVID-19 by racial, socioeconomic and geographical factors with Drs. Jasmine Marcelin of the University of Nebraska Medical Center and Damani Piggott of Johns Hopkins.

Guest moderator Dr. Neil Skolnik discusses IDSA's new COVID-19 Diagnostic Guidelines (bit.ly/2zp7Tdz) with guideline panelists & IDSA Board Members Angie Caliendo of Brown Medicine & Dr. Kim Hanson of the University of Utah.

Guest moderator Dr. Neil Skolnik discusses IDSA’s new Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19 with guideline panelist Dr. John Lynch, FIDSA. 

IDSA Leadership Institute faculty member Dr. Joshua Hartzell discusses the unique challenges presented by the pandemic for those leading teams in times of crisis with Dr. Wendy Armstrong of Emory University & Constance Benson of University of California, San Diego. For information on how to obtain CME credit, visit: https://bit.ly/3aVHvVL Disclaimer: The views expressed in this podcast are those of the author and do not reflect the official policy of the Department of Army/Navy/Air Force, Department of Defense, or U.S. Government.

Dr. Wendy Armstrong of Emory University and Constance Benson of University of California, San Diego share the biggest challenges they're facing during the COVID-19 pandemic.

We discuss the need for specialized housing for frontline medical professionals fighting the COVID-19 pandemic with Dr. Preeti Malani of the University of Michigan, Dr. Josh Barocas with Boston Medical Center and IDSA Board member Dr. John Lynch of The University of Washington.

Dr. Preeti Malani of the University of Michigan, Dr. Josh Barocas with Boston Medical Center and IDSA Board member Dr. John Lynch of The University of Washington sharing top challenges medical professionals are currently facing.

Social distancing and how it can prevent the spread of COVID-19 is discussed by Sandy Kemmerly, MD, FIDSA, IDSA Board Member Tina Tan, MD, FIDSA and HIVMA Chair-Elect Rochelle Walensky, MD, FIDSA. 

Mental health, PPE shortages, & testing are top challenges right now for front line medical professionals. Dr. Sandy Kemmerly with Ocshner Medical Center, Dr. Tina Tan of Northwestern University and Dr. Rochelle Walensky, Chair-Elect of HIVMA with Harvard University discuss. 

We discuss how to keep those living with HIV safe amid the threats of COVID-19 with Dr. Jennifer Chang of Kaiser Permanente Southern California, Dr. Rajesh Gandhi of Harvard University & Dr. Rachel Bender Ignacio with the University of Washington. 

Dr. Jennifer Chang of Kaiser Permanente Southern California & Dr. Rachel Bender Ignacio of the University of Washington share the challenges they're facing during the COVID-19 pandemic.

IDSA discusses the new IDSA Guidelines on the Treatment and Management of Patients with COVID-19 with guideline panelists, Dr. Adarsh Bhimraj with the Cleveland Clinic and Dr. Rajesh Gandhi of Massachusetts General Hospital.

In this episode, Dr. Adarsh Bhimraj with the Cleveland Clinic and Dr. Rajesh Gandhi of Massachusetts General Hospital share top challenges ID professionals are facing during the COVID-19 pandemic.

IDSA Board Members Dr. Angie Caliendo of Brown University and Dr. Kim Hanson of the University of Utah discuss the challenges surrounding COVID-19 testing and diagnostics, and how healthcare professionals are navigating them.

IDSA Board members Drs. Angie Caliendo of Brown University & Kim Hanson of the University of Utah discuss the challenges their teams are facing, including morale and little information on the biology of COVID-19. 

IDSA speaks with Dr. Mark Dougherty and ICU Nurse Leader Donita Cantrell of Baptist Health Lexington, Dr. Javeed Siddiqui of TeleMed2U & Dr. Ricardo Franco of the University of Alabama on PPE shortage, how it’s affecting medical professionals & the innovative ideas they have to deal with it.

Snapshot from the Frontlines is a new IDSA series that allows ID professionals to share their firsthand accounts as they fight the COVID-19 pandemic. Medical experts are given the opportunity to raise important issues and challenges affecting healthcare professionals. Today we speak to Dr. Mark Dougherty from Baptist Health Lexington, Dr. Javeed Siddiqui of TeleMed2U, Donita Cantrell, ICU Nurse Leader from Baptist Health Lexington and Dr. Ricardo Franco of The University of Alabama.

Oncologists Gary Lyman, MD, MPH of the Fred Hutchinson Cancer Research Center & Karen Winkfield of Wake Forest Baptist Comprehensive Cancer Center, & infectious disease physician Michael Boeckh, MD of the Fred Hutchinson Cancer Research Center share how to keep cancer patients safe amid the threats of the COVID-19 pandemic.

IDSA discusses the global effects of the COVID-19 pandemic with Dr. Anne Spaulding of Emory University, Dr. Mahmood Dalhat of the Nigerian Society of Infectious Diseases & Dr. Najwa Khuri-Bulos of the University of Jordan.

Is the COVID-19 supplemental funding bill enough? Drs. Andrew Pavia of the University of Utah, Matthew Zahn of Orange County Healthcare Agency, & Dawd Siraj of the University of Wisconsin-Madison join us for this week's episode. Time stamps: 02:17 - Is the $7.8 billion supplemental funding bill enough? (Dr. Pavia) 03:57 - Can this funding be useful at other types of health care facilities, such as community hospitals or outpatient settings? 04:54 - Is this level of funding enough to respond to the epidemic? (Dr. Zahn) 09:26 - Preparedness needs in public health(Dr. Zahn) 11:13 - Assessment of the global response so far(Dr. Siraj) 13:53 - Is the funding enough at a global level? (Dr. Siraj)

Drs. Angela Hewlett, Andre Kalil & Mark Rupp of the Nebraska Bio-Containment & Quarantine Units discuss how they've been evaluating some of the Americans quarantined on the Diamond Princess cruise ship.

IDSA speaks with Carlos del Rio, MD, FIDSA of Emory University, Javeed Siddiqui, MD, FIDSA of TeleMed2U and Ravina Kullar, PharmD, FIDSA of Expert Stewardship, Inc. The expert panelists discuss the Trump administration’s supplemental funding request, combatting misinformation on social media, the role telehealth will play in patient treatment, and the status of a COVID-19 vaccine. 00:49 - Where does the spread of COVID-19 stand today? 02:46 - Current treatment plans 09:06 - Will a vaccine be developed to prevent COVID-19? 09:46 – The role of telehealth in treating patients 13:10 - CDC's assessment that hospitals should prepare for a greater role for telehealth 14:02 - Will the funding request by the Trump administration be enough? 15:41 - Combatting misinformation on social media

This week, IDSA speaks with Drs. Krutika Kuppalli of Stanford University, Julie Vaishampayan, FIDSA of Stanislaus County Public Health, & Susan Kline of University of Minnesota about the latest COVID-19 news, including new findings from a China CDC paper and important steps to keep healthcare workers safe while preventing transmission.

IDSA speaks with Drs. Elisa Choi of Harvard Medical School, Amesh Adalja of Johns Hopkins Center for Health Security & Adeel Butt of Weill Cornell Medicine about the latest COVID-19 response efforts, public risk here and abroad, & the effects of recent travel restrictions.

IDSA’s Coronavirus Expert Panel, Dr. Daniel Lucey, FIDSA, Dr. Matthew Zahn, and CDC's Dr. Tim Uyeki & Dr. Satish Pillai share what you need to know about COVID-19. 

The Infectious Diseases Society of America's Guideline Update Podcast provides concise summaries of the most important IDSA guidelines. This episode discusses the Diagnosis and Treatment of Adults with Community-acquired Pneumonia - An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, 2019 For the full version of the guidelines presented, please go to www.idsociety.org or see the full article in Am J Respir Crit Care Med Vol 200, Iss 7, pp e45–e67, Oct 1, 2019 Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Joshua P. Metlay, M.D.,  Professor of Medicine, Massachusetts General Hospital, Professor, Department of Health Policy and Management,  Harvard T.H. Chan School of Public Health

The Infectious Diseases Society of America'sGuideline Update: Concise summaries of the most important IDSA guidelines. This episode discusses the 2018 Clinical Practice Guidelines for Asymptomatic Bacteiuria. For the full version of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2018. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Lindsay Nicolle, M.D., Professor Emeritus, Rady Faculty of Health Sciences, University of Manitoba and Consultant in Adult Infectious Diseases at the Health Sciences Centre and Winnipeg Regional Health Authority  

The Infectious Diseases Society of America'sGuideline Update: Concise summaries of the most important IDSA guidelines. This episode discusses the 2018 Update of the Clinical Practice Guidelines on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. For the full version of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2018. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Andrew T. Pavia, M.D. The George and Esther Gross Presidential Professor at the University of Utah, Chief of the Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City.

The Infectious Diseases Society of America'sGuideline Update: Concise summaries of the most important IDSA guidelines. This episode discusses the 2018 Clinical Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy (OPAT). For the full version of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2018. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Anne H. Norris, M.D.,  Medical Director, Penn Presbyterian Medical Center Infectious Diseases Specialty Clinic, Associate Professor of Clinical Medicinein the Division of Infectious Diseases, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania  

The Infectious Diseases Society of America's Guideline Update provides concise summaries of the most important IDSA guidelines. This podcast discusses the Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) published in Clinical Infectious Diseases. For details of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2018. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College,Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health L. Clifford McDonald, MD, Associate Director for Science, Division of Healthcare Quality Promotion, Centers for Disease Control, Atlanta, Georgia

    The Infectious Diseases Society of America's Guideline Update provides concise summaries of the most important IDSA guidelines. This podcast discusses the 2017 IDSA Clinical Practice Guidelines for the Managment of Chronic Pain in Patients Infected with HIV. For details of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2017. Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health R. Douglas Bruce, M.D., Chief of Medicine, Department of Medicine, Cornell Scott-Hill Health Center and Associate Clinical Professor of Medicine, Yale University, New Haven, Connecticut

The Infectious Diseases Society of America's Guideline Update: Concise summaries of the most important IDSA guidelines. This podcast discusses the 2017 IDSA Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. For details of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2017. Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Andi L. Shane, M.D,, MPH, MSc, Associate Professor in the Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, Georgia   Larry Pickering, M.D. is Adjunct Professor of Pediatrics at Emory University School of Medicine in Atlanta, Georgia, is past senior advisor to the director of the National Center for Immunization and Respiratory Diseases of the CDC and past Executive Secretary of the Advisory Committee on Immunization Practices (ACIP). He is editor of five editions the AAP Red Book; co-editor of the four editions of Principles and Practice of Pediatric Infectious Diseases.

The Infectious Diseases Society of America's Guideline Update: Concise summaries of the most important IDSA guidelines. This podcast discusses the 2017 American Thoracic Society/Infectious Diseases Society of America/CDC Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. For details of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2017;64(2):e1-e33.   Presented by:   Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health   David M. Lewinsohn, MD, PhD, Professor of Medicine, Division of Pulmonary and Critical Care, School of Medicine Oregon Health & Science University, Portland, Oregon

The Infectious Diseases Society of America's Guideline Update presents concise summaries of important IDSA guidelines. This podcast discusses the 2016 IDSA Guideline on Managment of Adults with Hospital-acquired and Ventilator-associated Pneumonia For details of the guidelines presented, please go to www.idsociety.org . Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Andre C. Kalil, M.D., Professor, Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha Mark Metersky, M.D., Professor of Medicine, Associate Chief of Service, Department of Medicine, Director, Center for Bronchiectasis Care, UConn Health, Pulmonary/Critical Care, Farmington, CT

The Infectious Diseases Society of America'sGuideline Update presents concise summaries of important IDSAguidelines. This podcast discusses the IDSA and SHEA Guideline onImplementing an Antibiotic Stewardship Program: Guidelines by theInfectious Diseases Society of America and the Society forHealthcare Epidemiology of America.For details of the guidelines presented, please goto www.idsociety.org .Presented by:Neil S. Skolnik, M.D., Professor of Family andCommunity Medicine, Temple University School of Medicine, AssociateDirector, Family Medicine Residency Program, Abington JeffersonHealth Tamar Barlam, M.D., Section of InfectiousDiseases, Boston University School of Medicine, Boston,MassachusettsSara Cosgrove, M.D., Division of InfectiousDiseases, Johns Hopkins University School of Medicine, Baltimore,Maryland

The Infectious Diseases Society of America's Guideline Update presents concise summaries of important IDSA guidelines. This podcast discusses the IDSA Clinical Practice Guideline for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults: 2015 .For details of the guidelines presented, please go to www.idsociety.org .Presented by:Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.Elie Berbari, M.D., Professor, Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota

The Infectious Diseases Society of America's Guideline Update presents concise summaries of  important IDSA guidelines.  This podcast discusses the IDSA Clinical Practice Guideline for Diagnosis and Management of Skin and Soft Tissue Infections: 2014 . For details of the guidelines presented, please go to www.idsociety.org .Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital. Dr. Dennis L. Stevens,  Chief, Infectious Diseases Section,   VA Medical Center,  Boise, ID.   

This podcast is part of the Hepatitis C Knowledge Network Webinar Series of the Infectious Diseases Society of America.  Today’s podcast is: Hepatitis C –Management after SVR  Presented by:Susanna Naggie, MDAssistant Professor of MedicineDivision of Infectious DiseasesDuke Clinical Research Institute Hosted by:Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.

This podcast is part of the Hepatitis C Knowledge Network Webinar Series of the Infectious Diseases Society of America.  Today’s podcast is: Hepatitis C – Patient Management  Presented by:Mark Sulkowski, MDProfessor of MedicineMedical Director, Viral Hepatitis CenterJohns Hopkins University School of Medicine Hosted by:Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.

This podcast is part of the Hepatitis C Knowledge Network Webinar Series of the Infectious Diseases Society of America.  Today’s podcast is: Hepatitis C in HIV-Coinfected PersonsPresented by:Kristin D. Marks, MD, MSAssistant Professor of MedicineDivision of Infectious DiseasesWeill Cornell Medical College Hosted by:

This podcast is part of the Hepatitis C Knowledge Network Webinar Series of the Infectious Diseases Society of America.  Today’s podcast is: Hepatitis C - Treatment Experienced Patients and Viral Resistance Presented by:David L. Wyles, MDAssociate Professor of MedicineDivision of Infectious DiseasesUniversity of California, San Diego Hosted by:

This podcast is part of the Hepatitis C Knowledge Network Webinar Series of the Infectious Diseases Society of America.  Today’s podcast is: Hepatitis C Treatment Decision MakingPresented by:David L. Thomas, MD, MPH, FIDSADirector, Division of Infectious DiseasesProfessor of Medicine, Division of Infectious DiseasesJohns Hopkins University School of MedicineHosted by:

This podcast is part of the Hepatitis C Knowledge Network Webinar Series of the Infectious Diseases Society of America.  Todays podcast is: What Every ID Fellow Needs to Know about HCV: Epidemiology, Screening, Testing and Risk ReductionPresented by:Arthur Kim, MD, FIDSA Director fo the Viral Hepatitis Clinic, Division of Infectious DiseasesMassachusetts General HospitalAssistant Professor of MedicineHarvard Medical School Hosted by:

The Infectious Diseases Society of America's lecture series provides easy access to many of the best lectures given throughout the year through the IDSA on important infectious disease topics. This podcast is part of the Hepatitis C Knowledge Network Webinar Series.   Presented by: David Thomas, MD, MPH, FIDSAProfessor of MedicineDirector, Division of Infectious DiseasesJohns Hopkins University School of Medicine Hosted by:

The Infectious Diseases Society of America's Guideline Update presents concise summaries of  important IDSA guidelines.  This podcast discusses the IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host, published online in Clinical Infectious Diseases, December 2013. For details of the guidelines presented, please go to www.idsociety.org .Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital. Lorry Rubin, MDDirector of Infectious Diseases, Cohen Children’s Medical Center of NY of the North Shore-LIJ Health System,Professor of Pediatrics, Hofstra North Shore-LIJ School of Medicine

The Infectious Diseases Society of America's Guideline Update presents concise summaries of  important IDSA guidelines.  This podcast discusses the Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America. For details of the guidelines presented, please go to www.idsociety.org .Presented by: Neil S. Skolnik, M.D.,Professor of Family and Community MedicineTemple University School of MedicineAssociate DirectorFamily Medicine Residency ProgramAbington Memorial HospitalMichael A. Horberg, MDExecutive DirectorMid-Atlantic Permanente Research Institute, Rockville, Maryland

The Infectious Diseases Society of America's lecture series provides easy access to many of the best lectures given throughout the year through the IDSA on important infectious disease topics. This podcast is part of the Hepatitis C Knowledge Network Webinar Series - Hepatitis C Epidemiology.Presented by: Michael Saag, MD, FIDSAIDSA Hepatitis Task Force Director, Center for AIDS ResearchUniversity of Alabama at BirminghamHosted by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.

The Infectious Diseases Society of America's lecture series provides easy access to many of the best lectures given throughout the year through the IDSA on important infectious disease topics. This podcast, recorded during ID Week 2012 discusses Diagnosis of Hepatitis C. Presented by: David Thomas, MD, MPHProfessor of MedicineDirector, Division of Infectious DiseasesJohns Hopkins University School of MedicineHosted by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.

The Infectious Diseases Society of America's Guideline Update presents concise summaries of important IDSA guidelines. This podcast discusses the IDSA Clinical Practice Guideline for Diagnosis and Management of Group A Streptococcal Pharyngitis. For details of the guidelines presented, please go to www.idsociety.org .Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital. Standord T. Shulman, MDChief, Division of Infectious Diseases Ann & Robert H. Lurie Childrens's Hospital of ChicagoVirginia H. Rogers Professor of Pediatric Infectious DiseasesNowthwestern University Feinberg School of Medicine

The Infectious Diseases Society of America's Guideline Update presents concise summaries of important IDSA guidelines. In this episode, Dr. Benjamen Lipsky joins us to discuss the 2012 IDSA Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Dr. Lipsky talks about the diagnosis of diabetic foot infections including clinical assessment, when imaging should be obtained, the place of culture and when to order a bone biopsy for osteomyelitis. Then Dr. Lipsky discusses the microbiology of diabetic foot infections, recommendations for wound care, and antibiotic recommendations. For details of the guidelines presented, please go to www.idsociety.org .Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital. Benjamin Lipsky, MD, FACP, FIDSA,FRPCPofessor of MedicineVA Puget SoundUniversity of Washington

The Infectious Diseases Society of America's Guideline Update presents concise summaries of important IDSA guidelines. For details of the guidelines presented, please go to www.idsociety.org .Presented by: Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital. Anthony Chow, MD, FACP, FRCPCPofessor Emeritus Division of Infectious DieasesDepartment of Medicine